United Kingdom
At GSK, we unite science, technology and talent to get ahead of disease together.
We prevent and treat disease with specialty medicines, vaccines and general medicines investing in four core therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; infectious diseases.
Our Ahead Together strategy means intervening early to prevent and change the course of disease, helping to protect people and support healthcare systems.
Currently, we invest around £1bn in research and development (R&D) in the UK annually with our global R&D hub at Stevenage continuing to be at the heart of the development of our pipeline of vital medicines, with a focus on the immune system, genetics, and advanced technologies.
Our culture powers our purpose, drives delivery of our strategy and helps make GSK a place where people can thrive. We are recognised in the Stonewall LGBT+ rights group as a top global employer and ranked in the Times Top 50 employers for women in the UK.
We also support our global and local communities. £1.7m has been raised by UK employees for Save the Children so far, with 100% of these funds being used to help provide UK families living on low incomes with essential household items, learning resources, and support that gives parents the skills, confidence and tools to help their children thrive.
Members of the public in the UK can obtain information about our products and areas of therapy by visiting our
Our locations in the UK
Contact details
GSK HQ
79 New Oxford Street
London
United Kingdom
WC1A 1DG
Healthcare professionals
Healthcare professionals (HCPs) in the UK can get information about our products and therapy areas by visiting GSKPro
As a healthcare company we regularly work with HCPs. From collaborating on clinical trials to providing high quality, balanced information about our medicines and vaccines, in all of our interactions we aim to be transparent about our work, operate with integrity, and always put the interests of patients first.
UK patients, journalists and members of public
In line with ABPI Code, we disclose payments for certain contracted services made to UK patients, journalists and members of the public, on an aggregate basis.
- 2024 Disclosure For Member Of Public, Patients & Journalists (PDF - 82.2KB)
- 2024 EFPIA HCPO Methodological Note English (PDF - 112.1KB)
- 2023 Disclosure For Member Of Public Patients Journalists (PDF - 193.2KB)
- 2023 EFPIA HCPO Methodological Note English (PDF - 149.2KB)
- 2022 Disclosure For Member Of Public Patients Journalists (PDF - 78.2KB)
- 2022 EFPIA HCPO Methodological Note English (PDF - 192.9KB)
Partnerships
Despite having some of the best people and research facilities, experience has shown us that we can achieve even more through strong partnerships.
These can be with the NHS, other companies, non-profit organisations and the academic world. In fact, it’s a key element in our business strategy, which helps us develop innovative new medicines and vaccines but also helps improve access to treatments and patient care
GSK-sponsored research projects
Discover GSK-sponsored research projects which explore healthcare challenges and opportunities. Here you will find relevant projects aimed at deepening understanding of key topics with the aim of helping to contribute towards improved patient outcomes.
Joint working
We are actively involved in a wide number of joint working projects with the NHS throughout the UK. By working together we aim to improve the management of different conditions, introduce greater efficiency and to achieve our ambition to unite science, technology and talent to get ahead of disease together.
The projects outlined below were undertaken over the last five years and, over this period, codes, regulations and laws governing the areas covered by the studies may have changed. When reading the documents please be assured that all projects followed the particular standards in force at the time even though these may have subsequently changed.
All of the featured case studies are intended to give an overview of the individual project including its background, the potential benefits for the patient, the NHS, GSK and any other stakeholders.
Grants and donations
We recognise a responsibility to support activities in our medical community, whether related to medical education where there is patient need and common scientific interest, professional societies’ initiatives, or assisting healthcare organisations and projects that promote other healthcare goals. In all of our interactions we aim to be transparent about our work, operate with integrity, and always put the interests of patients first.
Carbon reduction plan
In accordance with UK Cabinet Office standards, the attachment below is GSK’s Carbon Reduction Plan completed in accordance with PPN 06/21 and associated guidance and reporting standards for Carbon Reduction Plans.
